Approval · Notice of Compliance 13866 · 2012
TRUSCIENT: Notice of Compliance 13866
Issued November 20, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13866
- Date
- November 20, 2012
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Osteoinductive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRUSCIENT | 02396882 | Cancelled Pre Market |
Medicinal ingredients
- DIBOTERMIN ALFA 0.2 MG per ML